Figure 7
From: Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response
RNH1 predicts the response to several therapies in BLCA. (A) Correlations between RNH1 and molecular subtypes using different algorithms and BLCA signatures. (B) Correlations between RNH1 and the enrichment scores of several therapeutic signatures based on ssGSEA. (C) Boxplot presentation of several therapeutic signatures from panel (B). (D) Correlation between RNH1 and BLCA-related drug-target genes screened from the DrugBank database. *p < 0.05.
